Overall, these data support a role for BET proteins in modulating circulating IL6 and PTHrP levels and suggest that the BET inhibitor (+)-JQ1 restrains cancer cachexia through the reduction of IL6 and other cachectic factors. Here, PTHLH is linked to cancer.